Investing.com - GlaxoSmithKline ADR reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations.
GlaxoSmithKline ADR announced earnings per share of £1.01 on revenue of £12.52B. Analysts polled by Investing.com anticipated EPS of £0.7834 on revenue of £11.88B.
GlaxoSmithKline ADR shares are up 7% from the beginning of the year and are trading at £39.98 , down-from-52-week-high.They are under-performing the FTSE 100 which is up 12.48% from the start of the year.
GlaxoSmithKline ADR shares lost 0.51% in intra-day trade the report.
GlaxoSmithKline ADR follows other major Healthcare sector earnings this month
GlaxoSmithKline ADR's report follows an earnings beat by J&J on October 19, who reported EPS of £2.6 on revenue of £23.34B, compared to forecasts EPS of £2.35 on revenue of £23.64B.
Thermo Fisher Scientific had beat expectations on Wednesday with third quarter EPS of £5.76 on revenue of £9.33B, compared to forecast for EPS of £4.68 on revenue of £8.33B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar